0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.83%
Revenue growth at 50-75% of 0425.HK's 14.22%. Martin Whitman would worry about competitiveness or product relevance.
2.90%
Gross profit growth under 50% of 0425.HK's 14.76%. Michael Burry would be concerned about a severe competitive disadvantage.
6.20%
EBIT growth below 50% of 0425.HK's 17.18%. Michael Burry would suspect deeper competitive or cost structure issues.
35.35%
Positive operating income growth while 0425.HK is negative. John Neff might view this as a competitive edge in operations.
-19.07%
Negative net income growth while 0425.HK stands at 26.99%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-9.25%
Negative EPS growth while 0425.HK is at 27.78%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-5.78%
Negative diluted EPS growth while 0425.HK is at 27.78%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-10.94%
Share reduction while 0425.HK is at 0.94%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-14.43%
Reduced diluted shares while 0425.HK is at 0.48%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
349.14%
Dividend growth above 1.5x 0425.HK's 176.69%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-29.11%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-271.62%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
82239.74%
10Y revenue/share CAGR above 1.5x 0425.HK's 488.41%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
44.10%
5Y revenue/share CAGR under 50% of 0425.HK's 120.80%. Michael Burry would suspect a significant competitive gap or product weakness.
12.96%
3Y revenue/share CAGR under 50% of 0425.HK's 33.69%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
565.21%
10Y OCF/share CAGR above 1.5x 0425.HK's 336.94%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-83.91%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-64.35%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
467.39%
Net income/share CAGR above 1.5x 0425.HK's 280.78% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-50.51%
Negative 5Y net income/share CAGR while 0425.HK is 99.79%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-54.74%
Negative 3Y CAGR while 0425.HK is 13.54%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
104.46%
3Y equity/share CAGR above 1.5x 0425.HK's 31.94%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-29.68%
Negative 5Y dividend/share CAGR while 0425.HK stands at 467.65%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-88.67%
Negative near-term dividend growth while 0425.HK invests at 212.03%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
No Data
No Data available this quarter, please select a different quarter.
-2.99%
Inventory is declining while 0425.HK stands at 4.57%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.78%
Negative asset growth while 0425.HK invests at 14.15%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
18.40%
BV/share growth above 1.5x 0425.HK's 1.45%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-30.04%
We’re deleveraging while 0425.HK stands at 69.59%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-0.76%
We cut SG&A while 0425.HK invests at 12.23%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.